• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreHIVLiver DiseaseSleep DisordersBiosimilarsCovid-19AsthmaEye CareMultiple SclerosisPost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsSubstance Use DisorderType II Inflammation
Spotlight
A Collaboration That Will Help Payers Recognize the Potential Digital Health Can Bring to PatientsAMCP AnnualAsembia’s 2022 Specialty Pharmacy SummitAMCP NexusThe Improving Patient Access PodcastWet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment ApproachesParadigms in Insulin Use for Type 2 DiabetesPBMI National ConferenceRespiratory ConditionsShort on staff? Efficiency—not hiring—may be the best answerSupporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Resource CentersSee All >
  • HIV
  • Liver Disease
  • Sleep Disorders
  • Biosimilars
  • Covid-19
  • Asthma
  • Eye Care
  • Multiple Sclerosis
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Substance Use Disorder
  • Type II Inflammation
Spotlight
  • A Collaboration That Will Help Payers Recognize the Potential Digital Health Can Bring to Patients
  • AMCP Annual
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Nexus
  • The Improving Patient Access Podcast
  • Wet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment Approaches
  • Paradigms in Insulin Use for Type 2 Diabetes
  • PBMI National Conference
  • Respiratory Conditions
  • Short on staff? Efficiency—not hiring—may be the best answer
  • Supporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Challenges and Considerations in Treatment of Adult Spinal Muscular Atrophy

Key opinion leader discusses considerations for adult patients with spinal muscular atrophy (SMA) including disease burden, treatment evaluation, and the use of real-world evidence.

EP. 1: Identifying Adult Patients with Spinal Muscular Atrophy

December 21st 2020

EP. 2: Impact of Spinal Muscular Atrophy on Quality of Life

December 21st 2020

EP. 3: Spinal Muscular Atrophy and Healthcare Resource Utilization

December 21st 2020

EP. 4: Importance of Establishing Care Early in SMA Diagnosis

December 21st 2020

EP. 5: Treatment Challenges in Spinal Muscular Atrophy Patients

December 21st 2020

EP. 6: Spinal Muscular Atrophy Treatment Goals and Considerations

December 21st 2020

EP. 7: Quantifying and Measuring Treatment Success in SMA

December 21st 2020

EP. 8: Utilizing Real-World Data to Drive Evidence-Based SMA Treatment

December 21st 2020